As of 2025-07-15, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (425.19) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -111.0%.
The range of the Relative Valuation is (397.50) - (461.70) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 18.8x | 17.2x |
| Forward P/E multiples | 16.2x - 19.4x | 17.6x |
| Fair Price | (397.50) - (461.70) | (425.19) |
| Upside | -110.3% - -111.9% | -111.0% |
| Date | P/E |